Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DoximityDOCS +2.79%82 Cash-to-Debt is 73.50 as of Mar. 2026, which is at its 10-year median of 73.50. GuruFocus rates DOCS with a GF Score™ of 82/100 and a GF Value™ of $49.40 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Doximity ranks better than 89.07% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Doximity's cash to debt ratio for the quarter that ended in Mar. 2026 was 73.50.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Doximitycould pay off its debt using the cash in hand for the quarter that ended in Mar. 2026.
The historical rank and industry rank for Doximity's Cash-to-Debt or its related term are showing as below:
DOCS'
s Cash-to-Debt Range Over the Past 10 Years
Min: 37.87 Med: 73.5 Max: 732.89
Current: 73.5
During the past 8 years, Doximity's highest Cash to Debt Ratio was 732.89. The lowest was 37.87. And the median was 73.50.
DOCS's Cash-to-Debt is ranked better than 89.07% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 0.775
vs DOCS: 73.50
Doximity (NYSE:DOCS) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Doximity Cash-to-Debt Related Terms
Doximity Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Doximity's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Health Information Services subindustry, Doximity's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Doximity Cash-to-Debt vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Doximity's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Doximity's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Doximity (DOCS) has a Cash-to-Debt of 73.50 as of Mar. 2026. This is near median its historical median of 73.50. Over the past decade, Doximity's Cash-to-Debt has ranged from 37.87 to 732.89. According to the industry distribution chart, Doximity ranks #73 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 10.9%.
Is Doximity's Cash-to-Debt too high?
Doximity's current Cash-to-Debt of 73.50 is near median its 10-year median of 73.50. Over the past 10 years, this metric has ranged from a low of 37.87 to a high of 732.89. The Healthcare Providers & Services industry median Cash-to-Debt is 0.78. Doximity's value of 73.50 is 9383.9% above this industry median. Based on the distribution chart, Doximity ranks #73 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Doximity has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's Cash-to-Debt compare to PRVA and WAY?
According to the Healthcare Providers & Services industry distribution chart, Doximity ranks #73 out of 668 companies for Cash-to-Debt. This places Doximity in the top 11% of its industry — outperforming the majority of peers. The industry median Cash-to-Debt is 0.78. Doximity's value of 73.50 is 9383.9% above this benchmark. Historically, Doximity's own Cash-to-Debt has ranged from 37.87 to 732.89 over the past decade. While the company's 10-year median is 73.50 vs. the industry median of 0.78, Doximity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.78, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Doximity's current Cash-to-Debt of 73.50 is 9383.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Doximity's current Cash-to-Debt is 73.50, which is near median its own 10-year median of 73.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (DOCS) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.40, compared to a current price of $20.99 — trading 57.5% below its estimated fair value. The current Cash-to-Debt is 73.50, which is near median its 10-year median of 73.50 and 9383.9% above the Healthcare Providers & Services industry median of 0.78. Doximity's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Doximity (DOCS), the current Cash-to-Debt is 73.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Doximity (DOCS) Overvalued in 2026?
Based on GuruFocus' analysis, Doximity stock appears to be undervalued.
The current stock price of $20.99 is trading 57.5% below its estimated GF Value™ of $49.40.
GuruFocus considers Doximity to be Significantly Undervalued.
Key valuation signals for DOCS:
Cash-to-Debt: 73.50 (near median its 10-year median of 73.50)
GF Value™: $49.40 vs. price of $20.99 (57.5% below fair value)
Industry Position: 9383.9% above the Healthcare Providers & Services median (#73 of 668)
No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
82GF Score
Get the complete analysis for DOCS
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCS has been successfully added to your 
